STUDIES ON THE ANDROGENIC ACTIVITY OF 9α-FLUORO-11β - HYDROXY-17-METHYLTESTOSTERONE ('ULTANDREN'). II. A COMPARISON BETWEEN THE ANDROGENIC PROPERTIES OF 'ULTANDREN' AND TESTOSTERONE PROPIONATE

in Reproduction

Summary.

  1. The relative potency of parenterally administered 'Ultandren' compared with testosterone propionate is approximately 1 when seminal vesicle weight is used as an index of androgenic activity.
  2. Coagulating gland weight is not a suitable indicator of male sex hormone activity for use in the bioassay of 'Ultandren'.

If the inline PDF is not rendering correctly, you can download the PDF file here.

 

     An official journal of

    Society for Reproduction and Fertility

 

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 36 10 1
PDF Downloads 40 15 1